A COVID-19 vaccine developed by Quebec-based pharmaceutical firm Medicago is facing a hurdle in the approval process at the WHO due to the company’s links to cigarette maker Philip Morris International. Source
A COVID-19 vaccine developed by Quebec-based pharmaceutical firm Medicago is facing a hurdle in the approval process at the WHO due to the company’s links to cigarette maker Philip Morris International. Source